Adaptimmune Therapeutics PLC business relationships

Companies named in Adaptimmune Therapeutics PLC’s 10-K filed 2025-03-24, and public companies whose annual reports name Adaptimmune Therapeutics PLC. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 6.1 / 10
AI naming: 100 / 100
Agent readiness: 5 / 100
AI adoption: 0 / 100

Named in Adaptimmune Therapeutics PLC’s annual report 7

GSK plc (GSK)Customer5.5
“The Company had three collaboration customers during the year-ended December 31, 2024, which are Galapagos, Genentech and GSK, and two customers to whom product revenue sales were made.” SEC filing
GSK plc (GSK)Licensor5.5
“...operations primarily through sales of equity securities, cash receipts under our Astellas Collaboration Agreement, Galapagos, Genentech and GSK Collaboration and License Agreements and GSK Termination and Transfer Agreement, government grants and research and development tax and expenditure credits.” SEC filing
GSK plc (GSK)Partner5.5
“Genentech and GSK collaborations” SEC filing
Genentech, IncCustomer4.7
“The Company had three collaboration customers during the year-ended December 31, 2024, which are Galapagos, Genentech and GSK, and two customers to whom product revenue sales were made.” SEC filing
Genentech, IncLicensor4.7
“On September 3, 2021, the Company entered into a Strategic Collaboration and License Agreement with Genentech, Inc. and F.” SEC filing
Genentech, IncPartner4.7
“Prior collaborations with Genentech, relating to the research of "off-the-shelf" cell therapies, and GSK, relating to the transition of the NY-ESO and PRAME programs, have now either terminated or been concluded.” SEC filing
Universal Cells, Inc.Licensor4.6
“Collaboration and License Agreement, dated January 13, 2020, by and between Universal Cells, Inc. and Adaptimmune Limited (incorporated by reference to Exhibit 10.4 to our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 27, 2020).” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.